CEO: Roger L. Hawley.
Revenue: $23.4 million for 2010; no revenue in 2009.
Net loss: $73.6 million for 2010; $45.9 million in 2009.
No. of local employees: 26.
Headquarters: San Diego.
Year founded: 2006.
Stock symbol and exchange: ZGNX on Nasdaq.
Company description: A pharmaceutical company that develops and commercializes products that treat central nervous system disorders and pain.
Key factors for success: The company uses a proprietary technology called DosePro for delivering injection drugs under the skin without a needle, and it develops new pharmaceutical products based on existing, already-proven medications.